GENE ONLINE|News &
Opinion
Blog

Hearing Loss
Innovation Sensorineural Hearing LossClinical Trial
Pioneering Trial for Hearing Loss Medication Yields Promising Insights Despite Falling Short in Results
2024-03-06
Trials & Approvals Hearing Loss
Fennec’s PEDMARK Finally Gains FDA Approval to Treat Chemo-Induced Hearing Loss
2022-09-22
Special Lawsuit
3M Creates $1 Billion Trust in Attempt to Resolve Military Earplug Lawsuit
2022-07-27
R&D Hearing Loss
Overcoming Aging Related Hearing Loss- A Possibility In The Not So Distant Future
2022-05-18
In-Depth Hearing Loss
Fennec Submits Hearing Loss Drug for Third Time After Prior FDA Approval Rejections
2022-04-28
In-Depth Gene Editing
Successful Gene-Editing to Reverse Deafness Scores Another Win for Gene Therapy
2020-06-07
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top